Logothetis CJ - Search Results

1

Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial.

Corn PG, Heath EI, Zurita A, Ramesh N, Xiao L, Sei E, Li-Ning-Tapia E, Tu SM, Subudhi SK, Wang J, Wang X, Efstathiou E, Thompson TC, Troncoso P, Navin N, Logothetis CJ, Aparicio AM. Corn PG, et al. Among authors: logothetis cj. Lancet Oncol. 2019 Oct;20(10):1432-1443. doi: 10.1016/S1470-2045(19)30408-5. Epub 2019 Sep 9. Lancet Oncol. 2019. PMID: 31515154 Free PMC article. Clinical Trial.

2

Phase II study of interferon-alpha and chemotherapy (5-fluorouracil and mitomycin C) in metastatic renal cell cancer.

Sella A, Logothetis CJ, Fitz K, Dexeus FH, Amato R, Kilbourn R, Wallace S. Sella A, et al. Among authors: logothetis cj. J Urol. 1992 Mar;147(3):573-7. doi: 10.1016/s0022-5347(17)37309-3. J Urol. 1992. PMID: 1538431 Clinical Trial.

3

Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.

Dexeus FH, Logothetis CJ, Sella A, Fitz K, Amato R, Reuben JM, Dozier N. Dexeus FH, et al. Among authors: logothetis cj. J Clin Oncol. 1990 Feb;8(2):325-9. doi: 10.1200/JCO.1990.8.2.325. J Clin Oncol. 1990. PMID: 2137163

4

Successful treatment of pure endodermal sinus tumors in adult men.

Chong CD, Logothetis CJ, von Eschenbach AC, Ayala AG, Samuels ML. Chong CD, et al. Among authors: logothetis cj. J Clin Oncol. 1988 Feb;6(2):303-7. doi: 10.1200/JCO.1988.6.2.303. J Clin Oncol. 1988. PMID: 2448426

5

Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.

Dexeus FH, Logothetis CJ, Sella A, Finn L. Dexeus FH, et al. Among authors: logothetis cj. Am J Clin Oncol. 1989 Aug;12(4):350-4. doi: 10.1097/00000421-198908000-00015. Am J Clin Oncol. 1989. PMID: 2667326 Clinical Trial.

6

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

7

The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.

Daliani DD, Eisenberg PD, Weems J, Lord R, Fueger R, Logothetis CJ. Daliani DD, et al. Among authors: logothetis cj. J Urol. 1995 May;153(5):1587-91. J Urol. 1995. PMID: 7536271 Clinical Trial.

8

Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies.

Tu SM, Hossan E, Amato R, Kilbourn R, Logothetis CJ. Tu SM, et al. Among authors: logothetis cj. J Urol. 1995 Nov;154(5):1719-22. J Urol. 1995. PMID: 7563331 Clinical Trial.

9

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.

Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ. Logothetis CJ, et al. J Clin Oncol. 1995 Sep;13(9):2272-7. doi: 10.1200/JCO.1995.13.9.2272. J Clin Oncol. 1995. PMID: 7666085 Clinical Trial.

10

Phase II trial of low dose gamma-interferon in metastatic renal cell carcinoma.

Ellerhorst JA, Kilbourn RG, Amato RJ, Zukiwski AA, Jones E, Logothetis CJ. Ellerhorst JA, et al. Among authors: logothetis cj. J Urol. 1994 Sep;152(3):841-5. doi: 10.1016/s0022-5347(17)32587-9. J Urol. 1994. PMID: 8051732 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters